6-51883145-T-A

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_138694.4(PKHD1):​c.7298A>T​(p.Asp2433Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00193 in 1,612,624 control chromosomes in the GnomAD database, including 57 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.010 ( 29 hom., cov: 32)
Exomes 𝑓: 0.0011 ( 28 hom. )

Consequence

PKHD1
NM_138694.4 missense

Scores

8
10

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 3.28
Variant links:
Genes affected
PKHD1 (HGNC:9016): (PKHD1 ciliary IPT domain containing fibrocystin/polyductin) The protein encoded by this gene is predicted to have a single transmembrane (TM)-spanning domain and multiple copies of an immunoglobulin-like plexin-transcription-factor domain. Alternative splicing results in two transcript variants encoding different isoforms. Other alternatively spliced transcripts have been described, but the full length sequences have not been determined. Several of these transcripts are predicted to encode truncated products which lack the TM and may be secreted. Mutations in this gene cause autosomal recessive polycystic kidney disease, also known as polycystic kidney and hepatic disease-1. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007316977).
BP6
Variant 6-51883145-T-A is Benign according to our data. Variant chr6-51883145-T-A is described in ClinVar as [Benign]. Clinvar id is 167483.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.01 (1530/152288) while in subpopulation AFR AF= 0.034 (1413/41540). AF 95% confidence interval is 0.0325. There are 29 homozygotes in gnomad4. There are 703 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 29 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PKHD1NM_138694.4 linkuse as main transcriptc.7298A>T p.Asp2433Val missense_variant 46/67 ENST00000371117.8 NP_619639.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PKHD1ENST00000371117.8 linkuse as main transcriptc.7298A>T p.Asp2433Val missense_variant 46/671 NM_138694.4 ENSP00000360158 P2P08F94-1
PKHD1ENST00000340994.4 linkuse as main transcriptc.7298A>T p.Asp2433Val missense_variant 46/615 ENSP00000341097 A2P08F94-2

Frequencies

GnomAD3 genomes
AF:
0.0100
AC:
1524
AN:
152170
Hom.:
29
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0340
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00556
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.000147
Gnomad OTH
AF:
0.00860
GnomAD3 exomes
AF:
0.00275
AC:
690
AN:
251176
Hom.:
12
AF XY:
0.00197
AC XY:
267
AN XY:
135758
show subpopulations
Gnomad AFR exome
AF:
0.0359
Gnomad AMR exome
AF:
0.00223
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000131
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000150
Gnomad OTH exome
AF:
0.00147
GnomAD4 exome
AF:
0.00108
AC:
1577
AN:
1460336
Hom.:
28
Cov.:
30
AF XY:
0.000950
AC XY:
690
AN XY:
726594
show subpopulations
Gnomad4 AFR exome
AF:
0.0352
Gnomad4 AMR exome
AF:
0.00248
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000162
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000729
Gnomad4 OTH exome
AF:
0.00303
GnomAD4 genome
AF:
0.0100
AC:
1530
AN:
152288
Hom.:
29
Cov.:
32
AF XY:
0.00944
AC XY:
703
AN XY:
74472
show subpopulations
Gnomad4 AFR
AF:
0.0340
Gnomad4 AMR
AF:
0.00555
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000147
Gnomad4 OTH
AF:
0.00851
Alfa
AF:
0.00168
Hom.:
5
Bravo
AF:
0.0120
ESP6500AA
AF:
0.0340
AC:
150
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.00347
AC:
421
Asia WGS
AF:
0.00173
AC:
6
AN:
3478
EpiCase
AF:
0.000164
EpiControl
AF:
0.0000593

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpJul 18, 2019Variant summary: PKHD1 c.7298A>T (p.Asp2433Val) results in a non-conservative amino acid change located in the Pectin lyase fold (IPR012334) of the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0035 in 282570 control chromosomes, predominantly at a frequency of 0.035 within the African or African-American subpopulation in the gnomAD database, including 20 homozygotes. The observed variant frequency within African or African-American control individuals in the gnomAD database is approximately 5 fold of the estimated maximal expected allele frequency for a pathogenic variant in PKHD1 causing Polycystic Kidney and Hepatic Disease phenotype (0.0071), strongly suggesting that the variant is a benign polymorphism found primarily in populations of African or African-American origin. To our knowledge, no occurrence of c.7298A>T in individuals affected with Polycystic Kidney and Hepatic Disease and no experimental evidence demonstrating its impact on protein function have been reported. One ClinVar submission (evaluation after 2014) classified the variant as benign. Based on the evidence outlined above, the variant was classified as benign. -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Nov 25, 2013- -
Autosomal recessive polycystic kidney disease Benign:2
Benign, no assertion criteria providedclinical testingNatera, Inc.May 11, 2017- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingGeneDxMar 27, 2020- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.13
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Benign
0.26
T;.
Eigen
Uncertain
0.27
Eigen_PC
Uncertain
0.35
FATHMM_MKL
Benign
0.69
D
LIST_S2
Uncertain
0.88
D;D
MetaRNN
Benign
0.0073
T;T
MetaSVM
Uncertain
-0.11
T
MutationAssessor
Uncertain
2.5
M;M
MutationTaster
Benign
1.0
D;D
PrimateAI
Benign
0.46
T
PROVEAN
Uncertain
-2.6
D;N
REVEL
Uncertain
0.40
Sift
Benign
0.039
D;D
Sift4G
Benign
0.25
T;T
Polyphen
0.67
P;P
Vest4
0.58
MVP
0.97
MPC
0.27
ClinPred
0.023
T
GERP RS
5.6
Varity_R
0.16
gMVP
0.77

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs76895755; hg19: chr6-51747943; API